default author photo

Mark Ladinsky

California Institute of Technology - Division of Biology and Biological Engineering

SCHOLARLY PAPERS

3

DOWNLOADS

119

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

A Protective Role for the Lectin CD169/Siglec-1 During SARS-CoV-2 Infection

Number of pages: 83 Posted: 21 Jul 2023
Yale University - Section of Infectious Diseases, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University - Department of Microbial Pathogenesis, University of Illinois at Urbana-Champaign - Department of Microbiology, University of Regensburg - Department of Nephrology, University of Illinois at Urbana-Champaign - Department of Microbiology, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Yale University - Section of Infectious Diseases and Yale University - Department of Microbial Pathogenesis
Downloads 54 (1,031,043)

Abstract:

Loading...

Siglec-1, CD169, SARS-CoV-2 MA10, IL-10, Inflammasome, CD8+ T cells, Alveolar type I, Alveolar type II, macrophages

2.

Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy

Number of pages: 85 Posted: 01 Apr 2021
Yale University - Section of Infectious Diseases, Centre de Recherche du CHUM, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Yale University - Department of Microbial Pathogenesis, McGill University - Department of Microbiology and Immunology, Centre de Recherche du CHUM, Centre de Recherche du CHUM, Centre de Recherche du CHUM, Centre de Recherche du CHUM, University of Western Ontario, Uniformed Services University of the Health Sciences - Infectious Disease Division, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, Centre de Recherche du CHUM, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Regensburg - Department of Nephrology, Yale University - Section of Infectious Diseases, Yale University - Department of Immunobiology, The University of Western Ontario - Molecular Medicine Research Laboratories, University of Western Ontario - Department of Microbiology and Immunology, University of Vermont - Division of Immunobiology, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Centre de Recherche du CHUM, - Division of Vaccine Research, California Institute of Technology - Division of Biology and Biological Engineering, Yale University - Department of Microbial Pathogenesis, Centre de Recherche du CHUM, Yale University - Section of Infectious Diseases and Yale University - Department of Microbial Pathogenesis
Downloads 36 (1,290,922)
Citation 2

Abstract:

Loading...

SARS-CoV-2, COVID-19, nanoluciferase, bioluminescence imaging, neutralizing antibodies, convalescent patients, human ACE2 transgenic mice, monocytes, natural killer cells, monocytes, pathogenesis, inflammatory cytokines, Fc effector functions

3.

PPARγ Downregulation in Colonic CD8+ T Cells Results in Epithelial Barrier Disruption in People with HIV on Antiretroviral Therapy

Number of pages: 47 Posted: 04 Nov 2024
Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard University - Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard University - Ragon Institute of MGH, MIT and Harvard, Harvard University - Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology - Koch Institute for Integrative Cancer Research, California Institute of Technology - Division of Biology and Biological Engineering, California Institute of Technology - Division of Biology and Biological Engineering, Memorial Sloan Kettering Cancer Center, University of KwaZulu-Natal, University of KwaZulu-Natal, Massachusetts Institute of Technology (MIT) - Institute for Medical Engineering and Science, Harvard University - Ragon Institute of MGH, MIT and Harvard, Africa Health Research Institute, Harvard University - Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Harvard University - Ragon Institute of MGH, MIT and Harvard and Independent
Downloads 29 (1,359,097)

Abstract:

Loading...

HIV, immunometabolism, intestinal epithelial cells, barrier disruption, tissue resident memory T cells, fatty acid oxidation, immune-epithelial interactions, tissue homeostasis